These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Hereditary haemorrhagic telangiectasia: state of the art. Fiorella ML; Ross DA; White RI; Sabbà C; Fiorella R Acta Otorhinolaryngol Ital; 2004 Dec; 24(6):330-6. PubMed ID: 15952682 [TBL] [Abstract][Full Text] [Related]
49. [Surgical treatment of the endonasal manifestations of Rendu-Osler disease]. Gignoux M; Martin H; Cajgfinger H; Gignoux B; Gadot P J Med Lyon; 1970 Nov; 51(197):1967-8 passim. PubMed ID: 4949976 [No Abstract] [Full Text] [Related]
50. Free-flap reconstruction for the management of life-threatening hereditary hemorrhagic telangiectasia. Choi JW; Joo YH; Jeong WS; Jang YJ Auris Nasus Larynx; 2017 Oct; 44(5):607-611. PubMed ID: 27616747 [TBL] [Abstract][Full Text] [Related]
52. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells. Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064 [TBL] [Abstract][Full Text] [Related]
53. Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia. Vickery CL; Kuhn FA South Med J; 1996 Jan; 89(1):78-80. PubMed ID: 8545698 [TBL] [Abstract][Full Text] [Related]